| Consensus guidelines for the use and interpretation of angiogenesis assays |
86 |
| Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
34 |
| miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target |
30 |
| BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathways |
30 |
| Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis |
24 |
| Mouse models of Alzheimer's disease cause rarefaction of pial collaterals and increased severity of ischemic stroke |
23 |
| Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions |
23 |
| Angiogenesis in pancreatic cancer: current research status and clinical implications |
21 |
| The therapeutic potential of targeting the endothelial-to-mesenchymal transition |
21 |
| CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions |
20 |
| Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia |
19 |
| Cellular self-assembly into 3D microtissues enhances the angiogenic activity and functional neovascularization capacity of human cardiopoietic stem cells |
18 |
| PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation |
18 |
| Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma |
17 |
| Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA) |
17 |
| Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia |
16 |
| Different angioregulatory activity of monovalent galectin-9 isoforms |
16 |
| AutoTube: a novel software for the automated morphometric analysis of vascular networks in tissues |
15 |
| Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases |
15 |
| Noninvasive induction of angiogenesis in tissues by external suction: sequential optimization for use in reconstructive surgery |
14 |
| Understanding the evolving phenotype of vascular complications in telomere biology disorders |
14 |
| SNAI an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization |
14 |
| Leptin is a physiological regulator of skeletal muscle angiogenesis and is locally produced by PDGFR and PDGFR expressing perivascular cells |
13 |
| Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer |
13 |
| Selective IKK2 inhibitor IMD0354 disrupts NF-kappa B signaling to suppress corneal inflammation and angiogenesis |
13 |
| The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) |
12 |
| High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation |
12 |
| The regulatory network of miR-141 in the inhibition of angiogenesis |
12 |
| Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling |
12 |
| miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells |
12 |
| Pre-culture in endothelial growth medium enhances the angiogenic properties of adipose-derived stem/stromal cells |
10 |
| Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation |
10 |
| Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells |
10 |
| TSPYL5-mediated inhibition of p53 promotes human endothelial cell function |
10 |
| Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering |
10 |
| Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI |
9 |
| IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells |
9 |
| Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization |
9 |
| Spatiotemporal heterogeneity and patterning of developing renal blood vessels |
9 |
| Regulation of angiogenesis by microRNAs in cardiovascular diseases |
9 |
| Interleukin-22 promotes tumor angiogenesis |
8 |
| Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab |
8 |
| ADAM10 controls the differentiation of the coronary arterial endothelium |
8 |
| Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome |
8 |
| Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients |
7 |
| Staphylococcus aureus alpha toxin activates Notch in vascular cells |
7 |
| Visualization of endothelial cell cycle dynamics in mouse using the Flt-1/eGFP-anillin system |
7 |
| eNOS expression and NO release during hypoxia is inhibited by miR-200b in human endothelial cells |
7 |
| Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy |
7 |
| Notch signaling controls sprouting angiogenesis of endometriotic lesions |
7 |
